QubeHealth, a healthcare payments startup based in Mumbai, is currently in discussions to secure $6-9 million in a series A funding round within the next three to four months. The funding is expected to come from a Japanese fund, a Singaporean fund, and existing investors such as Inflection Point Ventures, Keiretsu Forum, Axiomatic Ventures, New Horizon Ventures, Mohit Burman (Chairman of Dabur India), and various family offices. A significant portion of this investment will be allocated towards enhancing QubeHealth's artificial intelligence capabilities, particularly for predictive spend pattern analysis, and strengthening its financial security features. Additionally, the startup plans to develop an online healthcare marketplace within its app, listing hospitals, clinics, pharmacies, and diagnostic centers across different cities and neighborhoods. Following this funding round, QubeHealth's valuation is projected to double to Rs 400 crore, marking a significant increase from its previous valuation of Rs 200 crore less than six months ago. Founded in 2020 by Chris George and Gagan Kapur, QubeHealth primarily operates as a B2B startup, offering two main products: Qube Pay, a UPI-based payments feature providing cashback of up to 10 percent per transaction, and Qube Cash, a healthcare credit line offering up to Rs 10 lakh with no-cost EMIs for up to 12 months, exclusively available to employees of partnered corporates.
QubeHealth, a startup focused on healthcare payments, is currently in discussions to secure between $6 million to $9 million in its series A funding round.
Updated: Feb 23
Comments